Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick B Ryan

Showing results (111-120 of 163) with videos related to

Pageof 17
Sort By:
BMC Medical Research Methodology|May 8, 2020
Feasibility and evaluation of a large-scale external validation approach for patient-level prediction in an international data network: validation of models predicting stroke in female patients newly diagnosed with atrial fibrillationJenna M Reps, Ross D Williams, Seng Chan You, et al.
EGEMS (Washington, DC)|February 4, 2017
Multisite Evaluation of a Data Quality Tool for Patient-Level Clinical Data SetsVojtech Huser, Frank J DeFalco, Martijn Schuemie, et al.
Lancet (London, England)|November 1, 2019
Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysisMarc A Suchard, Martijn J Schuemie, Harlan M Krumholz, et al.
Korean Circulation Journal|October 24, 2019
Comparison of First-Line Dual Combination Treatments in Hypertension: Real-World Evidence from Multinational Heterogeneous CohortsSeng Chan You, Sungjae Jung, Joel N Swerdel, et al.
EGEMS (Washington, DC)|May 21, 2015
Transparent reporting of data quality in distributed data networksMichael G Kahn, Jeffrey S Brown, Alein T Chun, et al.
Frontiers in Pharmacology|May 13, 2022
Factors Influencing Background Incidence Rate Calculation: Systematic Empirical Evaluation Across an International Network of Observational DatabasesAnna Ostropolets, Xintong Li, Rupa Makadia, et al.
Hypertension (Dallas, Tex. : 1979)|July 26, 2021
Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort StudyRuiJun Chen, Marc A Suchard, Harlan M Krumholz, et al.
Epilepsia|July 7, 2017
Risk of angioedema associated with levetiracetam compared with phenytoin: Findings of the observational health data sciences and informatics research networkJon D Duke, Patrick B Ryan, Marc A Suchard, et al.
Pharmacoepidemiology and Drug Safety|August 29, 2019
Diabetic ketoacidosis in patients with type 2 diabetes treated with sodium glucose co-transporter 2 inhibitors versus other antihyperglycemic agents: An observational study of four US administrative claims databasesLu Wang, Erica A Voss, James Weaver, et al.
Pharmacoepidemiology and Drug Safety|October 9, 2025
Recommendations to Enable Broader Use of Real-World Evidence to Inform Decision-Making Throughout Pharmacovigilance Signal ManagementG Niklas Norén, Katherine Donegan, Monica A Muñoz, et al.
Pageof 17

Showing results (111-120 of 163) with videos related to

Sort By:
Pageof 17
BMC Medical Research Methodology|May 8, 2020
Feasibility and evaluation of a large-scale external validation approach for patient-level prediction in an international data network: validation of models predicting stroke in female patients newly diagnosed with atrial fibrillationJenna M Reps, Ross D Williams, Seng Chan You, et al.
EGEMS (Washington, DC)|February 4, 2017
Multisite Evaluation of a Data Quality Tool for Patient-Level Clinical Data SetsVojtech Huser, Frank J DeFalco, Martijn Schuemie, et al.
Lancet (London, England)|November 1, 2019
Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysisMarc A Suchard, Martijn J Schuemie, Harlan M Krumholz, et al.
Korean Circulation Journal|October 24, 2019
Comparison of First-Line Dual Combination Treatments in Hypertension: Real-World Evidence from Multinational Heterogeneous CohortsSeng Chan You, Sungjae Jung, Joel N Swerdel, et al.
EGEMS (Washington, DC)|May 21, 2015
Transparent reporting of data quality in distributed data networksMichael G Kahn, Jeffrey S Brown, Alein T Chun, et al.
Frontiers in Pharmacology|May 13, 2022
Factors Influencing Background Incidence Rate Calculation: Systematic Empirical Evaluation Across an International Network of Observational DatabasesAnna Ostropolets, Xintong Li, Rupa Makadia, et al.
Hypertension (Dallas, Tex. : 1979)|July 26, 2021
Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort StudyRuiJun Chen, Marc A Suchard, Harlan M Krumholz, et al.
Epilepsia|July 7, 2017
Risk of angioedema associated with levetiracetam compared with phenytoin: Findings of the observational health data sciences and informatics research networkJon D Duke, Patrick B Ryan, Marc A Suchard, et al.
Pharmacoepidemiology and Drug Safety|August 29, 2019
Diabetic ketoacidosis in patients with type 2 diabetes treated with sodium glucose co-transporter 2 inhibitors versus other antihyperglycemic agents: An observational study of four US administrative claims databasesLu Wang, Erica A Voss, James Weaver, et al.
Pharmacoepidemiology and Drug Safety|October 9, 2025
Recommendations to Enable Broader Use of Real-World Evidence to Inform Decision-Making Throughout Pharmacovigilance Signal ManagementG Niklas Norén, Katherine Donegan, Monica A Muñoz, et al.
Pageof 17